genitourinary disorders
Medical Aspects of Long Term Renal Replacement Therapy
Hyperphosphatemia
 Hyperphosphatemia , a consequence of phosphate retention due to low glomerular filtration rate (GFR), increases risk of soft-tissue calcification, especially in coronary arteries and heart valves, when calcium (Ca) 2 to 3 grams with each meal is an option for patients who develop hypercalcemia while taking calcium-containing phosphate binders. Some patients (eg, those hospitalized with Acute Kidney Injury (AKI) and very high serum phosphate concentrations) require addition of aluminum-based phosphate binders, but these drugs should be used short-term only (eg, 1 to 2 weeks as needed) to prevent aluminum toxicity. 